Back to MA Mirae Asset Global Investments Co., Ltd.

IMVTIMVT

Showing 9 of 18 quarters

Position history for MAMirae Asset Global Investments Co., Ltd.'s holdings in Immunovant, Inc.

Yes. Mirae Asset Global Investments holds 10,555 shares of IMVT (Immunovant), worth $356,548, as of its Q3 2026 13F filing. It increased the position by 1,373 shares (+15.0%) from Q2 2026. Mirae Asset Global Investments has held IMVT since Q2 2022, across 18 quarterly 13F filings.

Current Value

$356,548

Current Shares

10,555

Total Value Change

+$208,210

Total Shares Change

+5,261

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q3
Latest
Increased
10,555
+14.9%
$356,5480.0%$33.78
27
2026-Q2
Decreased
9,182
-13.5%
$353,7820.0%$38.53
0
2026-Q1
Increased
10,616
+24.6%
$263,7010.0%$24.84
28
2025-Q4
Increased
8,517
+26.4%
$216,5020.0%$25.42
28
2025-Q3
Increased
6,739
+2.1%
$108,6330.0%$16.12
22
2025-Q2
Increased
6,603
+11.4%
$105,6480.0%$16.00
24
2025-Q1
Increased
5,928
+21.2%
$108,8970.0%$17.09
26
2024-Q4
Decreased
4,891
-7.6%
$119,7810.0%$24.77
0
2024-Q3
Increased
5,294
+21.4%
$148,3380.0%$28.02
27

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used